NewsRx

Search our medical news database

Industry News

Blood Brain Barrier Deficient Transgenic Mouse To Be Marketed

Published in Gene Therapy Weekly, February 13th, 1995

GenPharm International Inc., Mountain View, California, announced that the company will start marketing a new transgenic mouse model, the MDR1A-Mouse.

This mouse model carries a functional deficiency in the blood brain barrier. It is applicable to a wide range of central nervous system research, including neurotoxicology, drug transport, multi-drug resistance and studies of neurotrophic factor function. GenPharm acquired an exclusive world-wide license for this mouse strain and associated technologies from the Netherlands Cancer Institute (NCI).

Dr. Alfred H. Schinkel and his colleagues at the NCI developed the blood brain barrier deficient mouse...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook